PMID: 18714519Aug 22, 2008Paper

The guideline 'Recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology

Nederlands tijdschrift voor geneeskunde
Mariette GoddijnW M Ankum

Abstract

--In 2007, the Dutch Society for Obstetrics and Gynaecology issued a revised version of the 1999 guideline on recurrent miscarriage. --The new guideline was developed according to the principles of evidence-based guideline development and includes levels of evidence. --The guideline contains recommendations for effective diagnosis and treatment and explicitly mentions certain diagnostic tests and treatments that should be avoided. --After a thorough investigation of a couples'-history, the type of diagnostic tests that should be offered to the couple can be determined. Patients with a low risk of having cytogenetic abnormalities or thrombophilia may be excluded from parental karyotyping and thrombophilia screening, respectively. --Women with confirmed antiphospholipid antibody syndrome should be offered anticoagulation treatment before and during subsequent pregnancies. --Effective therapy for unexplained recurrent miscarriage is lacking. However, the probability of a successful future pregnancy is high. This probability can be estimated based on the number of previous miscarriages and maternal age.

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

The Journal of Family Planning and Reproductive Health Care
Andrew W Horne, Claire I Alexander
European Journal of Obstetrics, Gynecology, and Reproductive Biology
Sohinee BhattacharyaSiladitya Bhattacharya
© 2022 Meta ULC. All rights reserved